Ranibizumab and pegaptanib for the treatment of age-related macular degeneration

Technology appraisal guidance
Reference number: TA155
Published: 27 August 2008
Last updated: 20 May 2024

Appendix B: proposal paper presented to the Institute's Guidance Executive

Appendix B: proposal paper presented to the Institute's Guidance Executive

Appendix B: proposal paper presented to the Institute's Guidance Executive
19 May 2014
(528.75 Kb 34 sec)

Adobe Acrobat reader required.

Adobe Acrobat reader required.

This page was last updated: 15 May 2014